4.6 Article

Imaging of Metabolic Status in 3D Cultures with an Improved AMPK FRET Biosensor for FLIM

Journal

SENSORS
Volume 16, Issue 8, Pages -

Publisher

MDPI
DOI: 10.3390/s16081312

Keywords

FRET; FLIM; AMPK; spheroid; 2-photon; biosensor; TCSPC; 3D culture

Funding

  1. UK Biotechnology and Biological Sciences Research Council [BBSRC BB/M006786/1]
  2. MRC Clinical Sciences Centre
  3. Imperial College London
  4. Institute of Chemical Biology EPSRC
  5. BBSRC [BB/M006786/1] Funding Source: UKRI
  6. MRC [MC_U120027537] Funding Source: UKRI
  7. Biotechnology and Biological Sciences Research Council [BB/M006786/1] Funding Source: researchfish
  8. Medical Research Council [MC_U120027537] Funding Source: researchfish
  9. Medical Research Foundation [MRF-023-0002-S-CHENN] Funding Source: researchfish

Ask authors/readers for more resources

We describe an approach to non-invasively map spatiotemporal biochemical and physiological changes in 3D cell culture using Forster Resonance Energy Transfer (FRET) biosensors expressed in tumour spheroids. In particular, we present an improved Adenosine Monophosphate (AMP) Activated Protein Kinase (AMPK) FRET biosensor, mTurquoise2 AMPK Activity Reporter (T2AMPKAR), for fluorescence lifetime imaging (FLIM) readouts that we have evaluated in 2D and 3D cultures. Our results in 2D cell culture indicate that replacing the FRET donor, enhanced Cyan Fluorescent Protein (ECFP), in the original FRET biosensor, AMPK activity reporter (AMPKAR), with mTurquoise2 (mTq2FP), increases the dynamic range of the response to activation of AMPK, as demonstrated using the direct AMPK activator, 991. We demonstrated 3D FLIM of this T2AMPKAR FRET biosensor expressed in tumour spheroids using two-photon excitation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available